1. 1. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season [Internet]. [cited 2019 May 23]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2013_south/en/
2. 2. Skowronski DM, Masro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25: 2842-2851, 2007.
3. 3. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized placebo-controlled clinical trials. Euro Surveill 18: 20585, 2013.
4. 4. Fukushima W, Hirota Y. Basic principles of test-negative design in evaluating influenza vaccine effectiveness. Vaccine 35: 4796-4800, 2017.
5. 5. Sugaya N, Shinjoh M, Nakata Y, et al. Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016. Vaccine 36: 1063-1071, 2018.